CB2R Deficiency Exacerbates Imiquimod-Induced Psoriasiform Dermatitis and Itch Through the Neuro-Immune Pathway

Background: Cannabinoid receptor 2 (CB2R) is a potential target for anti-inflammatory and pain therapeutics given its significant immunomodulatory and analgesic effects. However, the role of CB2R in imiquimod (IMQ)-induced psoriasiform dermatitis (PsD) and itch is poorly understood. Objective: To in...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Li, Liu, Xin, Ge, Wenqiang, Chen, Chao, Huang, Yuqiong, Jin, Zilin, Zhan, Muouyang, Duan, Xiaoru, Liu, Xinxin, Kong, Yi, Jiang, Jian, Li, Xuemei, Zeng, Xin, Li, Fei, Xu, Shibin, Li, Man, Chen, Hongxiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841964/
https://www.ncbi.nlm.nih.gov/pubmed/35173615
http://dx.doi.org/10.3389/fphar.2022.790712

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841964/
https://www.ncbi.nlm.nih.gov/pubmed/35173615
http://dx.doi.org/10.3389/fphar.2022.790712

Ejemplares similares